ADMA Biologics Inc (ADMA)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 138,983 | 21,632 | -39,365 | -58,374 | -64,915 |
| Total assets | US$ in thousands | 488,678 | 329,182 | 348,461 | 276,253 | 207,673 |
| Operating ROA | 28.44% | 6.57% | -11.30% | -21.13% | -31.26% |
December 31, 2024 calculation
Operating ROA = Operating income ÷ Total assets
= $138,983K ÷ $488,678K
= 28.44%
ADMA Biologics Inc's operating return on assets (operating ROA) has shown a significant improvement over the past years. The operating ROA was negative in December 31, 2020, and continued to improve steadily, reaching positive values in December 31, 2023 and December 31, 2024. This indicates that the company has been able to generate a higher operating income relative to its assets over the years, reflecting improved operational efficiency and profitability. The upward trend in operating ROA suggests that ADMA Biologics Inc has successfully managed its assets to generate increasing returns, which may be a positive sign for the company's financial health and performance.
Peer comparison
Dec 31, 2024